share_log

CASI Pharmaceuticals | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-James Huang(18.0%),Panacea Venture Healthcare Fund II, L.P.(17.4%), etc.

CASI製藥 | SC 13G/A:超過5%持股股東披露文件(修正)-James Huang(18.0%),Panacea Venture Healthcare Fund II, L.P.(17.4%)等

美股SEC公告 ·  2023/11/09 16:13
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息